Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: A retrospective study from the ebmt-saa working party

Haematologica

Volumn 95, Issue 6, 2010, Pages 976-982

  Bacigalupo, Andrea ^a   Socie', Gerard ^b   Lanino, Edoardo ^c   Prete, Arcangelo ^d   Locatelli, Franco ^e   Locasciulli, Anna ^f   Cesaro, Simone ^g   Shimoni, Avichai ^h   Marsh, Judith ⁱ   Brune, Mats ^j   van Lint, Maria Teresa ^a   Oneto, Rosi ^a   Passweg, Jacob ^k  

^a UNIVERSITY OF GENOA   (Italy)

^b SAINT LOUIS HOSPITAL   (France)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^g Transfusion Service   (Italy)

^h SHEBA MEDICAL CENTER   (Israel)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

Aplastic anemia; Fludarabine; Graft failure; Graft versus host disease; Unrelated transplants

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; DONOR; FEMALE; GRAFT FAILURE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; EUROPE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; VIDARABINE; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 77953184315     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.018267     Document Type: Article

References (20)

1. Maury S, Balere-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K, et al. French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica. 2007;92(5):589-96.
2. Deeg HJ, Amylon ID, Harris RE, Collins R, Beatty PG, Feig S, et al. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplant. 2001;7(4):208-15.
3. Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002;100(3):799-803.
4. Perez-Albuerne ED, Eapen M, Klein J, Gross TJ, Lipton JM, Baker KS, et al. Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. Br J Haematol. 2008; 141(2):216-23.
5. Storb R, Leisenring W, Anasetti C, Appelbaum FR, Buckner CD, Bensinger WI, et al. Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antitymocyte globulin. Blood. 1997;89(10):3890-1.
6. McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P, et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant. 1994;13(3):233-7.
7. Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E, et al; Severe Aplastic Anaemia Working Party of the European Blood and Marrow Transplant Group. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. Br J Haematol. 2009;144(6):933-45.
8. Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socié G, Maury S, et al. Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Fludarabine, cyclophos- phamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant. 2005;36(11):947-50.
9. Okuda S, Terasako K, Oshima K, Sato M, Nakasone H, Kako S, et al. Fludarabine, cyclophosphamide, anti-thymocyteglobu- lin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell trans- plantation for very severe aplastic anemia without affecting ovarian function. Am J Hematol. 2009;84(3):167-9.
10. Koh LP, Koh MB, Ng HY, Hwang WY, Goh YT, Linn YC, et al. Allogeneic hematopoiet- ic stem cell transplantation for patients with severe aplastic anemia following non-myeloablative conditioning using 200-cGy total body irradiation and fludarabine. Biol Blood Marrow Transplant. 2006;12(8):887-90.
11. Kumar R, Prem S, Mahapatra M, Seth T, Chowdhary DR, Mishra P, et al. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non- HEPA filter rooms for multiply transfused atients with severe aplastic anemia. Bone Marrow Transplant. 2006;37(8):745-9.
12. George B, Methews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve out- come in Indian patients undergoing allo- geneic stem cell transplantation for severe aplastic anemia. Bone Marrow Transplant. 2007;40(1):13-8.
13. Srinivasan R, Takahashi Y, McCoy JP, Espinoza-Delgado I, Dorrance C, Igarashi T, et al. Overcoming graft rejection in heav- ily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol. 2006;133 (3):305.
14. Resnick IB, Aker M, Shapira MY, Tsirigotis PD, Bitan M, Abdul-Hai A, et al. Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen. Br J Haematol. 2006;133 (6):649.
15. Maury S, Bacigalupo A, Anderlini P, Aljurf M, Marsh J, Socié G, et al. Improved out- come of patients older than 30 years receiv- ing HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine- based conditioning: a comparison with conventional conditioning regimen. Haematologica 2009;94(9):1312-5.
16. Pierga JY, Socie G, Gluckman E, Devergie A, Henry-Amar M, Bridier A, et al. Secondary solid malignant tumors occur- ring after bone marrow transplantation for severe aplastic anemia given thoraco- abdominal irradiation. Radiother Oncol. 1994;30(1):55-8.
17. Viollier R, Socié G, Tichelli A, Bacigalupo A, Korthof ET, Marsh J, et al. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant. 2008;41(1):45- 50.
18. Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 2007;110(4):1397-400.
19. Bacigalupo A, Dominietto A, Soracco M, Raiola AM, van Lint MT, Lamparelli T, et al. Rituximab prophylaxis of EBV reactiva- tion after alternative donor transplants following anti-thymocyte globulin-based con- ditioning regimens. Blood. 2008;112:abstr 2232.
20. van Dorp S, Pietersma Fì, Wölfl M, Verdonck LF, Petersen EJ, Lokhorst HM, et al. Rituximab treatment before reduced- intensity conditioning transplantation associates with a decreased incidence of exten- sive chronic GVHD. Biol Blood Marrow Transplant. 2009;15(6):671-8.